1. Home
  2. TCTM vs GLTO Comparison

TCTM vs GLTO Comparison

Compare TCTM & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCTM
  • GLTO
  • Stock Information
  • Founded
  • TCTM 2002
  • GLTO 2011
  • Country
  • TCTM China
  • GLTO Denmark
  • Employees
  • TCTM N/A
  • GLTO N/A
  • Industry
  • TCTM Other Consumer Services
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCTM Real Estate
  • GLTO Health Care
  • Exchange
  • TCTM Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • TCTM 8.1M
  • GLTO 6.5M
  • IPO Year
  • TCTM 2014
  • GLTO 2020
  • Fundamental
  • Price
  • TCTM $0.48
  • GLTO $4.95
  • Analyst Decision
  • TCTM
  • GLTO Buy
  • Analyst Count
  • TCTM 0
  • GLTO 1
  • Target Price
  • TCTM N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • TCTM 42.8M
  • GLTO 17.2K
  • Earning Date
  • TCTM 01-01-0001
  • GLTO 03-07-2025
  • Dividend Yield
  • TCTM N/A
  • GLTO N/A
  • EPS Growth
  • TCTM N/A
  • GLTO N/A
  • EPS
  • TCTM N/A
  • GLTO N/A
  • Revenue
  • TCTM $190,004,403.00
  • GLTO N/A
  • Revenue This Year
  • TCTM $99.90
  • GLTO N/A
  • Revenue Next Year
  • TCTM N/A
  • GLTO N/A
  • P/E Ratio
  • TCTM N/A
  • GLTO N/A
  • Revenue Growth
  • TCTM N/A
  • GLTO N/A
  • 52 Week Low
  • TCTM $0.18
  • GLTO $4.40
  • 52 Week High
  • TCTM $2.99
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • TCTM 47.73
  • GLTO 45.13
  • Support Level
  • TCTM $0.18
  • GLTO $4.70
  • Resistance Level
  • TCTM $0.89
  • GLTO $5.35
  • Average True Range (ATR)
  • TCTM 0.18
  • GLTO 0.41
  • MACD
  • TCTM 0.04
  • GLTO -0.01
  • Stochastic Oscillator
  • TCTM 26.18
  • GLTO 26.23

About TCTM Tarena International Inc.

TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: